In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome
BackgroundPoractant alfa (Curosurf®) and Bovactant (Alveofact®) are two animal-derived pulmonary surfactants preparations approved for the treatment of neonatal respiratory distress syndrome (nRDS). They differ in their source, composition, pharmaceutical form, and clinical dose. How much these diff...
Saved in:
Main Authors: | Francesca Ricci (Author), Fabrizio Salomone (Author), Elke Kuypers (Author), Daan Ophelders (Author), Maria Nikiforou (Author), Monique Willems (Author), Tobias Krieger (Author), Xabier Murgia (Author), Matthias Hütten (Author), Boris W. Kramer (Author), Federico Bianco (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2017-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Dose Effect of Poractant Alfa in Neonatal RDS: Analysis of Combined Data from Three Prospective Studies
by: Barbara Królak-Olejnik, et al.
Published: (2020) -
Acute Lung Functional and Airway Remodeling Effects of an Inhaled Highly Selective Phosphodiesterase 4 Inhibitor in Ventilated Preterm Lambs Exposed to Chorioamnionitis
by: Matthias Christian Hütten, et al.
Published: (2022) -
Effect of same dose varying concentration poractant alfa on outcomes in preterm infants under 32 weeks of age
by: A. V. Mostovoi, et al.
Published: (2023) -
A Randomized, Single-blind, Comparison Trial of Beractant (BeraksurfTM) versus Poractant Alfa (Curosurf®) in the Treatment of Respiratory Distress Syndrome in Preterm Infants
by: Manizheh Mostafa Gharehbaghi, et al.
Published: (2023) -
Comparison of Efficacy of Beractant and Poractant Treatment Performed with Minimal Invasive Technique
by: Selahattin Akar, et al.
Published: (2021)